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A large number of drug efﬂux transporters have been identiﬁed in Salmonella enterica serovar Typhi-
murium, and increased expression of these transporters confers drug resistance in this organism. Here
we compared the respiration activities of the wild-type strain and a mutant with nine deleted trans-
porters by phenotype microarray analysis. The mutant was susceptible to 66 structurally unrelated
compounds including many antibiotics, dyes, detergents, antihistamine agents, plant alkaloids, antide-
pressants, antipsychotic drugs, and antiprotozoal drugs. To investigate the effect of each transporter on
the susceptibilities to these drugs, we used the single transporter mutants, several multiple deletion
mutants, and the transporter overexpressor strains to determine minimum inhibitory concentrations of
ampicillin, erythromycin, minocycline, ciproﬂoxacin, orphenadrine, amitriptyline, thioridazine, and
chlorpromazine. The data indicate that the increased susceptibilities of the mutant lacking nine trans-
porter genes are mainly dependent on the absence of the acrAB efﬂux genes as well as the tolC gene. In
addition to the AcrAB-TolC efﬂux system, the results from the overexpressor strains show that AcrEF
confers resistance to these compounds as well as AcrAB of Escherichia coli, MexAB-OprM and MexXY-
OprM of Pseudomonas aeruginosa. The results highlight the importance of the efﬂux systems not only
for resistance to antibiotics but also for resistance to antihistamine agents, plant alkaloids, antidepres-
sants, antipsychotic drugs, and antiprotozoal drugs.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Japanese Society of Chemotherapy and
The Japanese Association for Infectious Diseases. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Bacterial drug resistance is often associated with drug efﬂux
transporters, which can decrease the cellular accumulation of
drugs [1]. Bacterial drug efﬂux transporters are classiﬁed into ﬁve
major groups on the basis of sequence similarity as major facili-
tator (MF) superfamily; resistanceenodulationecell division
(RND) family; small multidrug resistance (SMR) family; multidrug
and toxic compound extrusion (MATE) family; and ATP-binding
cassette (ABC) superfamily [2]. There are many drug efﬂux trans-
porters in Salmonella enterica serovar Typhimurium, including ﬁve
RND (AcrAB, AcrD, AcrEF, MdsABC, and MdtABC), two MF (EmrAB
and MdfA), one MATE (MdtK), and one ABC (MacAB) drugIndustrial Research, Osaka
pan. Tel.: þ81 06 6879 8545;
Nishino).
onbehalf of Japanese Society of Chem
org/licenses/by-nc-nd/4.0/).transport systems. Previously, we experimentally demonstrated
that these nine efﬂux systems are functional and they confer drug
resistance phenotypes in this organism [3]. Among the trans-
porters, deletion of the tolC, acrB or acrAB genes resulted in strains
with increased susceptibility to 16 antimicrobial agents and
chemical compounds including erythromycin, novobiocin, tetra-
cycline, chloramphenicol, nalidixic acid, norﬂoxacin, doxorubicin,
acriﬂavine, crystal violet, ethidium bromide, methylene blue,
rhodamine 6G, tetraphenylphosphonium bromide, benzalkonium
chloride, sodium dodecyl sulfate, and sodium deoxycholate.
However, the drug tolerance of Salmonella harboring these drug
efﬂux systems has been studied using only a limited number of
toxic compounds and antibiotics.
In the present study, we conducted phenotype microarray
analysis to study the drug tolerance mediated by efﬂux systems
using a broader panel of toxic compounds. To identify drug resis-
tance patterns modulated by drug efﬂux transporters, we used theotherapyand The Japanese Association for Infectious Diseases. This is an open access article
S. Yamasaki et al. / J Infect Chemother 22 (2016) 780e784 781wild-type strain ATCC14028s [4] and the mutant EG16588 lacking
nine efﬂux genes (DacrABDacrEFDacrDDmdtABCDmdsABCDemrAB
DmdfADmdtK::CmRDmacAB::KmR) [3] (Supplementary Table S1).
The respiratory activities of these strains were measured in
approximately 2000 different environments with a phenotypeTable 1
Chemical compounds that selectively decreased the respiration activity of the efﬂux mu
Plate Position Decrease in
PM12B E01, E02, E03, E04 374
PM17A G03, G04 107
PM12B A10 100
PM14A A09, A10 166
PM18C G03 63
PM13B G10, G11, G12 302
PM15B B09, B10, B11, B12 304
PM16A A09 70
PM20B B01, B02 128
PM20B F09, F10 121
PM14A H07 100
PM15B D01 101
PM14A A02, A03, A04 178
PM18C H07 131
PM11C C01, C02, C03 230
PM16A B03, B04 167
PM20B D05, D06 119
PM18C B06 95
PM11C H10 95
PM11C B10 85
PM11C E09, E10 99
PM16A B10 75
PM20B E06, E07 138
PM13B A05, A06, A07, A08 361
PM18C D11 86
PM17A E03 79
PM12B E09, E10 196
PM12B H09, H10 138
PM16A C11 82
PM15B D06, D07 185
PM19 G01, G02 134
PM20B A01, A02, A03 239
PM18C F07 78
PM17A D09, D10, D11 187
PM14A G01, G02, G03, G04 291
PM15B F09, F10, F11 320
PM15B F05, F06, F07, F08 349
PM13B H09, H10, H11, H12 281
PM15B C05, C06, C07, C08 276
PM19 A01, A02, A03, A04 357
PM12B H01, H02, H03 267
PM20B H09, H10, H11 249
PM12B A07, A08 159
PM11C A05, A06 122
PM11C C09 63
PM11C F05, F06, F07, F08 321
PM11C A09, A10, A11 230
PM20B B09, B10 450
PM20B C01, C02, C03 264
PM19 D05, D06 254
PM20B E01, E02 169
PM16A E09 79
PM20B D02, D03 125
PM16A F03 93
PM17A G12 95
PM16A A01 72
PM13B D02 96
PM14A F05, F06, F07 250
PM12B B01, B02 211
PM13B B01, B02 189
PM19 F01, F02 159
PM12B A01 107
PM13B A03 103
PM11C H01 85
PM11C D09, D10, D11 253
PM11C B05, B06, B07 253microarray from Biolog Inc (Supplementary material). The results
indicated that this mutant was susceptible to 66 structurally un-
related compounds (Table 1). In particular, the mutant was sus-
ceptible to many antibiotics, including b-lactams, such as
piperacillin, oxacillin, azlocillin, phenethicillin, penicillin G,tant EG16588 (D9) compared with the wild-type strain ATCC14028s.
respiration activity Chemical compound
2,4-Diamino-6,7-diisopropylpteridine
Chlorambucil
Carbenicillin
Sanguinarine
Triclosan
Triﬂuoperazine
5,7-Dichloro-8-hydroxy-quinaldine
5-Chloro-7-iodo-8-hydroxyquinoline
Orphenadrine
Pridinol
Promethazine
Phleomycin
Acriﬂavine
2-Phenylphenol
Bleomycin
Norﬂoxacin
Ciproﬂoxacin
Pipemidic acid
Oﬂoxacin
Lomeﬂoxacin
Nalidixic acid
Trimethoprim
Dodine
Dequalinium
Lidocaine
Niaproof
Benzethonium chloride
Dodecyltrimethyl ammonium bromide
Cetylpyridinium chloride
Domiphen bromide
Lauryl sulfobetaine
Amitriptyline
Tinidazole
Chlorpromazine
Chelerythrine
Puromycin
Oleandomycin
Tylosin
Fusidic acid
Josamycin
Spiramycin
Troleandomycin
Tetracycline
Chlortetracycline
Minocycline
Erythromycin
Lincomycin
Tetrazolium violet
Thioridazine
Iodonitro tetrazolium violet
Crystal violet
Rifamycin SV
Proﬂavine
Potassium tellurite
Cefoperazone
Cefotaxime
Cefuroxime
Piperacillin
Oxacillin
Azlocillin
Phenethicillin
Penicillin G
Ampicillin
Cephalothin
Nafcillin
Cloxacillin
S. Yamasaki et al. / J Infect Chemother 22 (2016) 780e784782ampicillin, nafcillin, and cloxacillin; quinolones, such as nor-
ﬂoxacin, ciproﬂoxacin, pipemidic acid, oﬂoxacin, lomeﬂoxacin, and
nalidixic acid; and macrolides, such as oleandomycin, tylosin,
josamycin, spiramycin, troleandomycin, and erythromycin. The
efﬂux mutant was also sensitive to dyes, such as acriﬂavine, and
detergents, such as dodecyltrimethyl ammonium bromide. In
addition to antimicrobial agents, the mutant lacking nine drug
efﬂux systems was sensitive to the following compounds: prom-
ethazine (an antihistamine agent); plant alkaloids, such as cheler-
ythrine (a protein kinase C inhibitor); antidepressants, such as
amitriptyline; antipsychotic drugs, such as chlorpromazine and
thioridazine; and antiprotozoal drugs, such as tinidazole. The drugTable 2
Susceptibility of Salmonella drug efﬂux transporter deleted strains to compounds.
Strain MIC (mg/ml)
ABPC
Salmonella enterica serovar Typhimurium
WT 2
DtolC 0.25
DacrB 0.13
DacrAB 0.13
DacrD 2
DacrEF 1
DmdtABC 2
DmdsABC 2
DemrAB 2
DmdfA 2
DmdtK 2
DmacAB 2
DemrAB DmdfA 2
DacrB tolC 0.25
DacrB acrD 0.13
DacrB acrEF 0.13
DacrB mdtABC 0.13
DacrB mdsABC 0.13
DacrAB acrEF 0.13
DacrAB acrEF acrD 0.13
DacrAB acrEF acrD mdtABC 0.13
DacrAB acrEF acrD mdtABC mdsABC 0.13
DacrAB acrEF acrD mdtABC mdsABC emrAB 0.13
DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA 0.13
DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA mdtK 0.13
DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA mdtK macAB (D9) 0.13
DacrB/vector N.D.
DacrB/pacrAB N.D.
DacrB/pacrDa N.D.
DacrB/pacrEF N.D.
DacrB/pmdsABCb N.D.
DacrB/pmdtABCc N.D.
DacrB/pemrABd N.D.
DacrB/pmdfAe N.D.
DacrB/pmdtKf N.D.
DacrB/pmacAB N.D.
Escherichia coli
WT 2
DacrB 1
DacrB/vector 1
DacrB/pacrAB (E. coli) 2
DacrBtolC 1
DacrBtolC/vector N.D.
DacrBtolC/pmexABM (P. aeruginosa) N.D.
DacrBtolC/pmexXYM (P. aeruginosa) N.D.
Abbreviations: ABPC, ampicillin; EM, erythromycin; MINO, minocycline; CPFX, ciproﬂoxac
N.D., not determined because the plasmids carry ampicillin resistance cassette.
a pacrD conferred novobiocin resistance (MIC, 4 mg/ml for DacrB/vector versus 256 mg
b pmdsABC conferred acriﬂavine resistance (MIC, 32 mg/ml for DacrB/vector versus 256
c pmdtABC conferred novobiocin resistance (MIC, 4 mg/ml for DacrB/vector versus 32 m
d pemrAB conferred novobiocin resistance (MIC, 4 mg/ml for DacrB/vector versus 16 mg
e pmdfA conferred chloramphenicol resistance (MIC, 1 mg/ml for DacrB/vector versus 8
f pmdtK conferred acriﬂavine resistance (MIC, 32 mg/ml for DacrB/vector versus 256 mefﬂux mutant possessed chloramphenicol and kanamycin resis-
tance marker genes inserted by the gene disruption method [3]
(Supplementary Table S1); therefore, it was reasonable to expect
that EG16588 would be resistant to chloramphenicol, thiamphe-
nicol, paromomycin, neomycin, and kanamycin as shown in the
Supplementary material.
In order to conﬁrm the results of phenotype microarray and
investigate the role of each efﬂux system in Salmonella suscepti-
bility to the toxic compounds, we measured minimum inhibitory
concentrations (MICs) of ampicillin, erythromycin, minocycline,
ciproﬂoxacin, orphenadrine, amitriptyline, thioridazine, and
chlorpromazine by using single efﬂux transporter mutants andEM MINO CPFX ORP AMP THD CPZ
256 4 0.031 1024 512 >1024 512
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
256 4 0.031 1024 512 >1024 512
256 2 0.016 1024 512 >1024 256
128 2 0.031 512 256 >1024 256
256 4 0.031 1024 512 >1024 512
256 4 0.031 1024 512 >1024 256
256 4 0.031 1024 512 >1024 512
256 2 0.031 1024 512 >1024 256
256 4 0.031 1024 512 >1024 512
256 4 0.031 1024 512 >1024 512
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
2 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
128 2 0.031 512 256 512 256
4 0.13 <0.008 256 64 32 32
128 2 0.031 512 256 256 256
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
4 0.25 <0.008 256 64 32 32
4 0.13 <0.008 256 64 32 32
8 0.13 <0.008 256 64 32 32
128 2 0.031 1024 256 512 128
4 0.13 <0.008 256 64 16 32
4 0.13 <0.008 256 64 16 32
128 1 0.016 512 256 256 128
2 0.13 <0.008 256 64 16 32
2 0.13 <0.008 256 64 16 32
64 2 0.031 512 256 512 128
256 2 0.031 512 256 256 64
in; ORP, orphenadrine; AMP, amitriptyline; THD, thioridazine; CPZ, chlorpromazine.
/ml for DacrB/pacrD) [Supplementary reference 7].
mg/ml for DacrB/pmdsABC) [Supplementary reference 7].
g/ml for DacrB/pmdtABC) [Supplementary reference 7].
/ml for DacrB/pemrAB) [Supplementary reference 7].
mg/ml for DacrB/pmdfA) [Supplementary reference 7].
g/ml for DacrB/pmdtK) [Supplementary reference 7].
S. Yamasaki et al. / J Infect Chemother 22 (2016) 780e784 783several multiple deletion mutants (Table 2). The mutants DtolC,
DacrB, DacrAB, DacrB tolC, DacrB acrD, DacrB acrEF, DacrB mdtABC,
DacrB mdsABC, DacrAB acrEF, DacrAB acrEF acrD, DacrAB acrEF acrD
mdtABC, DacrAB acrEF acrD mdtABC mdsABC, DacrAB acrEF acrD
mdtABC mdsABC emrAB, DacrAB acrEF acrD mdtABC mdsABC emrAB
mdfA, DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA mdtK, and
DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA mdtK macAB were
sensitive to all compounds more than 4-fold compared with the
wild-type strain whereas DacrD, DacrEFDmdtABC, DmdsABC, Dem-
rAB, DmdfA, DmdtK, DmacAB, and DemrAB mdfA exhibited almost
same MIC values to the compounds as the wild-type strainFig. 1. A. Growth of the wild-type strain (ATCC14028s), DacrB, DtolC, and D9 (EG16588) muta
(3 mg/ml ampicillin, 64 mg/ml amitriptyline, 384 mg/ml orphenadrine, 64 mg/ml thioridazin
ciproﬂoxacin). B. Ethidium bromide accumulation assay. The wild-type strain and the Dac
600 nm) was measured in the presence and the absence of chlorpromazine, thioridazine o(Table 2). The mutants which showed increased sensitivity to the
compounds above were commonly deleted with acrB, acrAB or tolC.
This indicates that the increased susceptibilities of the mutant
lacking nine efﬂux transporter genes are mostly dependent on the
absence of the acrAB efﬂux genes as well as the tolC gene.
In addition to the deletion mutants, we also measured MICs of
the compounds using the transporter overexpressor strains
(Table 2). Among the nine transporters in S. enterica, expression of
AcrAB and AcrEF gave resistance to DacrB against erythromycin,
minocycline, ciproﬂoxacin, orphenadrine, amitriptyline, thiorida-
zine, and chlorpromazine. Expression of AcrAB of Escherichia coli,nts of Salmonella cells in the presence and the absence of various chemical compounds
e, 1 mg/ml minocycline, 40 mg/ml chlorpromazine, 4 mg/ml erythromycin, 0.008 mg/ml
rB mutant were used. Fluorescence (excitation [ex.] at 530 nm and emission [em.] at
r amitriptyline.
S. Yamasaki et al. / J Infect Chemother 22 (2016) 780e784784MexAB-OprM and MexXY-OprM of Pseudomonas aeruginosa also
gave resistance to the E. coli DacrB mutant against all compounds
tested.
Growth curve of the wild-type strain, the DacrB, DtolC, and
DacrAB acrEF acrD mdtABC mdsABC emrAB mdfA mdtK macAB (D9)
mutants were also measured with or without ampicillin, amitrip-
tyline, orphenadrine, thioridazine, minocycline, chlorpromazine,
erythromycin, or ciproﬂoxacin (Fig. 1A). All the mutants grew
similarly as the wild-type strain without the compounds, however
the growth speed of the DacrB, DtolC, and D9 mutants were very
slow in the presence of ampicillin, amitriptyline, orphenadrine,
thioridazine, minocycline, chlorpromazine, erythromycin, and
ciproﬂoxacin (Fig. 1A).
The hypersusceptibilities of the DacrB or DtolC mutants against
antidepressants and antipsychotic drugs, such as chlorpromazine,
thioridazine and amitriptyline, suggested that these compounds
interact with the AcrAB-TolC efﬂux system. The levels of accumu-
lation of ethidium bromide by the wild-type ATCC14028s strain
compared with that by the DacrB mutant were determined in the
presence and the absence of chlorpromazine, thioridazine or
amitriptyline (Fig. 1B). In the presence of chlorpromazine, thiorid-
azine or amitriptyline, the wild-type strain accumulated more
ethidium bromide than it did without these compounds. All the
compounds had no effect upon the level of ethidium bromide
accumulation by the DacrBmutant (Fig.1B). These data suggest that
the compounds are substrates working as competitive inhibitors of
the AcrAB-TolC efﬂux system.
In this study, we compared the sensitivity of the wild-type
S. enterica ATCC14028s and its mutant EG16588, which lacked
nine drug efﬂux systems, to various chemical compounds using
Biolog phenotype microarrays. The results indicate the importance
of the drug efﬂux systems in Salmonella resistance to many struc-
turally unrelated compounds, including not only antibiotics, pig-
ments, and detergents but also antihistamine agents, plant
alkaloids, antidepressants, antipsychotic drugs, and antiprotozoal
drugs, which are substrates of the efﬂux transporters in S. enterica.
Previously, Bailey et al. also reported that S. enterica SL1344 mu-
tants lacking RND efﬂux transporter genes (acrB, acrD, and acrF)
exhibited signiﬁcantly poorer growth in the presence of chemical
agents [5]. In the present study, we showed that S. enterica
ATCC14028s mutant that lacked nine efﬂux genes, which belonged
to the RND, MF, MATE and ABC, exhibited increased sensitivity
against 66 compounds compared with the wild-type strain. It
should be noted that there was no difference in the phenotypes of
the wild type and the efﬂux mutant on plates PM1e10
(Supplementary material), which tested for differences in cellular
metabolism, such as carbon, nitrogen, phosphorus, and sulfur
sources; nutrient supplements; peptide nitrogen sources; osmo-
lytes; and pH. The differences between the wild type and efﬂux
mutant were only observed on plates PM11e20 (Supplementary
material), which contained several toxic compounds, including
antibiotics. Phenotype microarrays might be valuable tools for
initial screenings to investigate the effects of transporters in the
bacterial susceptibilities to various toxic compounds, however
additional experiments are necessary to characterize bacterial
transporters in detail.In addition to the results of phenotype microarray, we per-
formed MIC measurements of ampicillin, erythromycin, minocy-
cline, ciproﬂoxacin, orphenadrine, amitriptyline, thioridazine, and
chlorpromazine and bacterial growth curves in presence of these
compounds by using the single efﬂux transporter mutant, several
multiple deletion mutants, and strains overexpressing the trans-
porters. The data indicate that the increased susceptibilities of the
mutant lacking nine efﬂux transporter genes is mainly dependent
on the absence of the acrAB efﬂux genes as well as the tolC gene. It
was also revealed that the expression of AcrAB and AcrEF of
S. enterica confer resistance to these compounds as well as AcrAB of
E. coli, MexAB-OprM and MexXY-OprM of P. aeruginosa. From the
MICs data and ethidium bromide accumulation assay, it was sug-
gested that antidepressants and antipsychotic drugs, such as
chlorpromazine, thioridazine and amitriptyline, might be sub-
strates working as competitive inhibitors of the AcrAB-TolC efﬂux
system. Our results showed the importance of the efﬂux systems
not only for the intrinsic resistance to antimicrobial agents but also
for those to antihistamine agents, plant alkaloids, antidepressants,
antipsychotic drugs, and antiprotozoal drugs.
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